Axsome Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.28 |
Market Cap |
$900.57 M |
Shares Outstanding |
33.28 M |
Public Float |
20.74 M |
Address |
200 Broadway New York New York 10038 United States |
Employees | - |
Website | http://www.axsome.com |
Updated | 07/08/2019 |
Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY. |